---
schema_version: "secwatch.filing_event.v1"
accession: "0001062993-26-002900"
form_type: "8-K"
ticker: "MDCX"
cik: "0001997296"
company_name: "Medicus Pharma Ltd."
filed_at: "2026-05-27T20:45:00+00:00"
generated_at: "2026-05-27T20:47:48.649387+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Medicus Pharma closes $22M secured notes with Streeterville; receives Nasdaq MVLS non-compliance notice

## Summary
- Issued two secured promissory notes to Streeterville Capital: A-1 ($12.86M principal, net $12M) and B ($10M in DACA), maturing in 18 months.
- A-1 Note carries 8.75% interest and $834K OID; B Note 5% interest. Prepayment premiums of 110-115% apply.
- Proceeds support clinical development, strategic initiatives, and repayment of $2.5M YA II PN debenture.
- Nasdaq notified non-compliance with $35M MVLS requirement; company has 180 days to regain compliance by Nov 16, 2026.
- B Note can be exchanged for A Notes when A principal reduced by $2M; trigger events allow balance increases of 15%/5%.

## SEC filing metadata
- accession: 0001062993-26-002900
- form_type: 8-K
- ticker: MDCX
- cik: 0001997296
- company_name: Medicus Pharma Ltd.
- filed_at: 2026-05-27T20:45:00+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 2.03, 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1997296/000106299326002900/0001062993-26-002900-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1997296/000106299326002900/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062993-26-002900
- JSON: https://secwatch.observer/filing/0001062993-26-002900.json
- Plain text: https://secwatch.observer/filing/0001062993-26-002900.txt

## Source-grounded claims
- claim_id: c82acdec964b29c636cf58309c902970a1b95a16
  claim: Medicus Pharma Ltd. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5550(b)(1), 5550(b)(3), 5810(c)(3)(C)).
  evidence_excerpt: May 20, 2026, the Company received written notice (the "Notice") from the Listing Qualifications Department of the Nasdaq notifying the Company that it is not in compliance with the minimum Market Value of Listed Securit
  evidence_url: https://www.sec.gov/Archives/edgar/data/1997296/000106299326002900/0001062993-26-002900-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.